Maine Medicine Weekly Update
October 31, 2021

In This Issue
One Step Closer to COVID Vaccines for Kids; FDA Authorizes Vaccine for Children Ages 5-11
Identifying Child Maltreatment
Identify to Protect: Recognizing the Signs of Child Maltreatment
More COVID Guidance & News
US FDA & CDC Officially Expand Eligibility Recommendations For COVID-19 Booster Shots
Moderna COVID-19 Vaccine Booster Dose Webinar & Ordering Reminders
Further Clarification to The Moderna Guidance That Was Previously Sent to Providers
Upcoming Training Sessions for Pfizer COVID-19 Vaccines
New Standing Orders for Moderna, Janssen, & Pfizer with Booster Language Dose Information
Immunocompromised Americans who had a 3rd COVID-19 shot can now get a 4th
COVID-19 Monoclonal Antibody Therapies in Maine
US CDC Adds Certain Mental Health Conditions to List of High-Risk Individuals Eligible for Booster Shots
US Surgeon General Vivek Murthy on Vaccinating Kids, Mix and Match Boosters, Other Top Concerns
US Supreme Court Lets Maine Health Care Vaccine Mandate Stand
JAMA, NEJM Studies, Reports & Helpful Information
Top JAMA, JAMA Network, and New England Journal of Medicine Articles
Maine Track Teaching Opportunities
Teaching Opportunities in Tufts Medical School 'Maine Track'
FDA Rules Notices
FDA Moves to Allow Over-The-Counter Hearing Aids
Fraud Alert
Scammers Target Medical Conferences
Whaaaaatt ... ???
Surgeons in Egypt Remove Phone That Man Swallowed & Waited Six Months For It To ‘Pass Naturally’
Registration is Open! November 5th Governor's Office Opioid Response Seminar Series
Upcoming Specialty Society Meetings
Join us for an introduction to hospice services in our webinar on November 2nd: Let’s Talk Hospice!
AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
SUPPORT For ME Training and Technical Assistance Initiative Webinars on November 3 & December 1
Maine Independent Clinical Information Service: MICIS presentations & Academic Detailing
Physician (BC/BE in Family Medicine) - Mt. Abram Regional Health Center, (Kingfield, Maine)
Physician (BC/BE in Family Medicine) - Bingham Area Health Center

Search Back Issues




Follow Us:

One Step Closer to COVID Vaccines for Kids; FDA Authorizes Vaccine for Children Ages 5-11

The Food and Drug Administration on Friday, October 29th authorized the Pfizer COVID-19 vaccine for children ages 5-11, one of the final steps in making vaccines available to children under 12.

The Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age is administered as a two-dose primary series, 3 weeks apart, but is a lower dose (10 micrograms) than that used for individuals 12 years of age and older (30 micrograms).

What’s Next?

The US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) is scheduled to meet this week (Nov. 2 & 3) to discuss further clinical recommendations and how the vaccine should be used. If the panel gives favorable recommendations and CDC Director Rochelle Walensky accepts them, vaccinations can begin pending state guidance.

The Maine CDC has released guidance regarding the availability of Pediatric Pfizer. The Maine Immunization Program (MIP) will make the Pfizer COVID-19 vaccine for 5- 11-year-olds available for enrolled MIP Providers to order through ImmPact.

Important Note: Although the vaccine is available to order now, it cannot be administered until it has received final approval by the US CDC.

  • The ordering minimum will be 300 doses initially, but Maine CDC anticipates that a minimum of 100 doses will be available to order in late October. Packaging consists of 10-dose vials in cartons of 10 vials
  • The Maine Immunization Program will be working with all school districts to assist with orderingpediatric Pfizer vaccine and coordinating clinics.
  • Please be advised if you are a Federally Qualified Health Center or Rural Health Center, you will need to order the vaccine through ImmPact since this presentation will not be available through HRSA

·      The 5-11 year old population in Maine is ~79,000. Supply is not expected to be an issue.

Maine State survey data show that only ~30-35% of parents will want the vaccine for their kids immediately upon approval. The MMA has throughout the pandemic and will continue to advocate for physicians as a trusted source of medical advice and care for patients and families, and that participation in the vaccination process is imperative to keep Mainers healthy and safe.

ACIP Meeting Information and Resources:

Draft Agenda for November 2nd and 3rd

November 2nd—COVID-19 Vaccines (10:00 a.m. start)

November 3rd—Hepatitis Vaccines, Immunization Schedules, Orthopoxviruses Vaccines, Ebola Vaccine


Webcast Link to Watch Meetings


Read the FDA Press Release to learn more.

Pfizer/BioNTech submitted its clinical trial data to the FDA for emergency use authorization. The trials show the vaccine is 91 percent effective in preventing symptomatic disease for children ages 5 to 11 and was well-tolerated, with few side effects.

FDA briefing documents on the Pfizer-BioNTech COVID-19 vaccine, released before the FDA advisory panel meeting, indicated an immune response and that is was safe and effective in young children.

The White House recently unveiled its plans to vaccinate children between the ages of 5 and 11 years old, pending authorization by the Food and Drug Administration in the coming weeks. The distribution plan will rely on pediatricians, community health centers, schools, and pharmacies to put parents and children at ease, rather than the mass vaccination sites used in the initial rollout for adults.

Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©